Submission Details
| 510(k) Number | K904304 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 19, 1990 |
| Decision Date | October 26, 1990 |
| Days to Decision | 37 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
K904304 is an FDA 510(k) clearance for the DUPONT DIMENSION(R) TOBRAMLLYCIN(TOBR) METHOD, a Radioimmunoassay, Tobramycin (Class II — Special Controls, product code KLB), submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on October 26, 1990, 37 days after receiving the submission on September 19, 1990. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3900.
| 510(k) Number | K904304 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 19, 1990 |
| Decision Date | October 26, 1990 |
| Days to Decision | 37 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | KLB — Radioimmunoassay, Tobramycin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3900 |